SOURCES SOUGHT
A -- RFI-TRAINING FOR DESIGN IMPROVEMENTS
- Notice Date
- 3/30/2023 1:16:55 PM
- Notice Type
- Sources Sought
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- W6QK ACC-APG ABERDEEN PROVING GROU MD 21010-5424 USA
- ZIP Code
- 21010-5424
- Solicitation Number
- W911SR-23-S-TRAIN
- Response Due
- 4/17/2023 2:00:00 PM
- Point of Contact
- Susan E. Ruzicka, Phone: 301-915-5548
- E-Mail Address
-
susan.e.ruzicka2.civ@army.mil
(susan.e.ruzicka2.civ@army.mil)
- Description
- Objective: This is a Request for Information (RFI) for planning purposes only. It is not to be construed as a commitment by the Government nor will the Government pay for the information solicited.� No solicitation document exists or is guaranteed to be issued as a result of this RFI. The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical) and the Joint Program Executive Office for Chemical, biological, Radiological, and Nuclear Defense (JPEO-CBRND) is seeking information on the available capabilities and willingness of private entities (academic, non-profit, and commercial) to collaborate with the Government in the areas listed below. Background:� JPM CBRN Medical is interested in improving the U.S. industrial base for development and manufacturing of medical counter measure (MCM) products used by the U.S. military and allies to counteract chemical and biological threats. Investment in MCM manufacturing directly addresses readiness requirements across all the DoD�s Services, the whole of government, and allies, while providing risk reduction for these critically needed MCMs, ensuring both sustained and surge production for these lifesaving treatments for the Warfighter. Therapeutic pharmaceuticals against chemical, biological, radiological and nuclear (CBRN) warfare agents are required to support the Joint Forces across a range of military operations.� As such, the Department of Defense (DoD) has a need for developing and fielding systems that provide treatment for exposure to CBRN agents.� JPEO-CBRND is responsible for the development, procurement, fielding, and sustaining of medical treatment and prophylactic capabilities against CBRN threats.� The time needed for medical device design and development for parenteral drug delivery treatments is lengthened by following DoD�s Build-Test-Fix design framework [1]. Cyclic rounds of testing and fixing problems at the system level in the lab or field do not facilitate building reliability and robustness into the design. Important knowledge of design critical parameter effects on device performance is not easily or quickly gained in this framework requiring multiple rounds of system-level redesign and testing. Late-in-development discovered design failures drive the project schedule to the right and increase costs. Acquisition of device critical parameter knowledge and optimization of performance can be accelerated by adopting predictive device design frameworks such as Design for Six Sigma vs. a reactive design framework like Build-Test-Fix. Predictive design frameworks focus on optimizing critical design parameters at the subassembly and subsystem levels in the design. These iterations can be accelerated and reduce cost while not waiting until the entire system is built and tested. Requirements: The Government is seeking white papers outlining approaches for training and mentoring design teams not typically educated in design-outcome predictive frameworks and methods. The purpose of this RFI is to solicit information on the availability of U.S. based companies capable of providing training and mentoring to manufacturers contracted with the U.S. DoD for development of medical devices. The expectation is that these training sessions have already been developed. Performance Objectives:� The training should be specific for design-outcome predictive frameworks and method like Design for Six Sigma. Performer should show a successful past performance in conducting this training. One week on-line/in-person training should include a hands-on portion for practitioners to reinforce their learning experience. Expect to train leadership in addition to design team members in understanding the benefits and requirements of using a design-outcome predictive framework and methods for product development. Team-level follow-on mentorship and coaching expected during the duration of development which typically runs between 3 and 5 years. The Respondents shall provide the following in reply to this RFI, not to exceed 11 pages in total: Company Description (2 page maximum). Provide a brief description of company history, alliances and funding emphasizing experience in design-outcome predictive frameworks and methods training. Design-Outcome Predictive Method Training Description (5 page maximum) Description and discussion of any or all the capabilities described in the Performance Objectives section.� Innovative approaches that address the overarching program goals that do not precisely match the above Performance Objectives can be included. Provide a description of the design framework and methods to be used in this effort along with samples of training materials. Discussion of the maturity of the proposed approaches, including previous demonstrated use. Provide a high-level training schedule. Provide a Rough Order of Magnitude cost. Administration: The Government will retain comments and information received in response to this RFI. Proprietary information should be identified as Company Proprietary. Do not use Government security classification markings. All written responses must be received by COB on 17 April 2023. Responses should be sent by e-mail to:� usarmy.detrick.mcs.mbx.baa@mail.mil, with Subject Line denoting the Responding Organization and RFI Title. Material that is advertisement only in nature is not desired. Any solicitation subsequently released based on the responses to this RFI will be posted in Sam.gov. In addition, respondents are encouraged to view the Medical Countermeasures Broad Agency Announcement (BAA) in SAM.gov, keywords �CBRND BAA�.� For questions related to this RFI, please e-mail to:� usarmy.detrick.mcs.mbx.baa@mail.mil.� The Point of Contact for this RFI is Susan Ruzicka, at susan.e.ruzicka2.civ@army.mil. Reference List: [1]������� W. Fowlkers, Engineering Methods for Robust Product Design � Using Taguchi Methods in Technology and Product Development (Engineering Process Improvements Series). Reading, Massachusetts: Addison Wesley Longmen, Inc. (in English), 1995, p. 403.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/84dcda5fa38e40bbbe9a1b65d0609c6e/view)
- Place of Performance
- Address: USA
- Country: USA
- Country: USA
- Record
- SN06635936-F 20230401/230330230114 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |